Benadryl vs. Zyrtec: Sedation, Duration and Who Each One Suits

What you need to know

• Benadryl (diphenhydramine) is a first-generation antihistamine; Zyrtec (cetirizine) is a second-generation one.
• Benadryl commonly causes drowsiness and anticholinergic effects (dry mouth, blurred vision) because it crosses into the brain; Zyrtec causes far less sedation for most people.
• Benadryl lasts only about 4 to 6 hours and is dosed several times a day; Zyrtec is taken once daily and lasts around 24 hours.
• For everyday, ongoing allergy control, a non-drowsy once-daily option like Zyrtec is generally the better fit.
• Older, sedating antihistamines like Benadryl are generally advised against for regular use in older adults.
• Neither is a substitute for epinephrine in a severe allergic reaction — anaphylaxis is a 911 emergency.

The Key Difference: Generation

Benadryl and Zyrtec both block the H1 histamine receptor, but they belong to different generations of antihistamine, and that's what drives nearly every practical difference between them. Benadryl's active ingredient, diphenhydramine, is a first-generation antihistamine that readily crosses into the brain, which is why it commonly causes drowsiness and anticholinergic side effects. Zyrtec's active ingredient, cetirizine, is a second-generation antihistamine designed to stay mostly out of the brain, so it causes much less sedation. For the broader concept, see our first- vs. second-generation antihistamine guide.

Side-by-Side Comparison

The driving evidence most comparisons leave out

"Causes drowsiness" undersells what the research actually found, and this is the part worth reading twice if you drive.

In a randomised, placebo-controlled crossover trial published in the Annals of Internal Medicine, 40 licensed drivers with seasonal allergic rhinitis each drove for an hour in the Iowa Driving Simulator after four different treatments: fexofenadine, diphenhydramine 50 mg, alcohol to roughly 0.1% blood alcohol, and placebo.¹

• Driving was poorest after diphenhydramine — worse than after the alcohol dose.¹
• Performance after fexofenadine was similar to placebo.¹
• How drowsy people felt did not predict how badly they drove.¹

That last finding is the important one. The instinct is to think "I don't feel that sleepy, I'm fine to drive" — and the trial says that judgement is unreliable. Feeling alert on a first-generation antihistamine is not evidence that you are safe to drive. The label's own advice is to be careful driving or operating machinery, and to avoid alcohol on top.³

When Each One Fits

For everyday allergy symptoms — sneezing, runny nose, itchy eyes over days or weeks — Zyrtec's once-daily, low-sedation profile generally makes it the more practical choice. Benadryl is sometimes used for short-term or occasional situations, and some people take it at night, but its short duration, drowsiness, and anticholinergic effects make it a poor fit for regular daytime use. Relying on Benadryl as a routine sleep aid isn't recommended. For a comparison among the non-drowsy options specifically, see Claritin vs. Zyrtec and Claritin vs. Allegra.

What each label actually says

Both are sold from the same shelf, but the two Drug Facts labels ask very different things of you.

Benadryl (diphenhydramine)

• Children under 6: do not use. Ages 6 to under 12 take one tablet; 12 and over take one or two — and no more than 6 doses in 24 hours.³
• "Do not use to make a child sleepy." That instruction is printed on the label.³
• Excitability may occur, especially in children — the opposite of the sedation adults expect.³
• Ask a doctor first if you have glaucoma, trouble urinating from an enlarged prostate, or breathing problems such as emphysema or chronic bronchitis.³
• Do not combine it with any other product containing diphenhydramine — including creams and gels used on the skin. This is easy to do by accident when treating an itchy rash and hay fever at the same time.³
• Avoid alcohol; sedatives and tranquillisers add to the drowsiness.³

Zyrtec (cetirizine)

• One tablet once daily. Under 6, and adults 65 and over, the label says ask a doctor — as it does for liver or kidney disease.⁵
• "Drowsiness may occur"; avoid alcoholic drinks, and take care driving.⁵ In the trials behind the label, about 14% of people aged 12 and over reported drowsiness, and it was dose-related.⁴
• Not recommended while breastfeeding.⁵
• If you take it daily for months, be aware of the FDA warning about rare but severe itching after stopping long-term use of cetirizine or levocetirizine.⁷

See antihistamine side effects and taking two antihistamines together.

Is there still a place for Benadryl?

Yes — and it is worth being fair about it, because "never use it" is not what the evidence says either.

Diphenhydramine is effective, cheap, available everywhere, and comes in liquid and topical forms. It is reasonable for a short, occasional problem where sedation is acceptable and you are not driving: a one-off reaction to an insect bite, an itchy rash in the evening, a single night of misery during a bad pollen day. Clinicians also still reach for it in acute settings under supervision.

What it is not well suited to is routine, ongoing allergy control — four-to-six-hourly dosing, next-day grogginess, anticholinergic effects and the driving evidence all count against it, and current guidelines put second-generation antihistamines first for allergic rhinitis and hives.⁶

It is also not a sleep aid to lean on. Sedation is not the same as restorative sleep, tolerance to the sedative effect develops, and the label explicitly says not to use it to make a child sleepy.³ If you are reaching for it mainly to get to sleep, that is worth raising with a pharmacist or doctor rather than turning into a habit.

Safety Notes

• Older adults are generally advised to avoid regular use of first-generation antihistamines like Benadryl due to confusion, anticholinergic effects, and fall risk — see our allergies in older adults guide
• This is a formal recommendation, not just convention: the American Geriatrics Society Beers Criteria classes first-generation antihistamines as potentially inappropriate medications in older adults and recommends second-generation options instead, with dose adjustment for kidney function. Cumulative anticholinergic exposure is associated with increased risk of falls, delirium and dementia⁶, and diphenhydramine specifically is described as a high-risk medicine in older patients because of fall risk from dizziness, sedation and low blood pressure²
• Both can add to the sedating effects of alcohol; the effect is stronger with Benadryl — see antihistamines and alcohol
• Follow age and dosing directions on the label, especially for children — see our children's allergy medicine guide
• Neither pill replaces epinephrine for a severe allergic reaction; anaphylaxis needs epinephrine and 911

When to seek care

Practical next steps

Safe general steps

1. For ongoing allergies, choose a once-daily non-drowsy option like Zyrtec
2. Reserve sedating first-generation antihistamines for short-term or occasional use, if at all
3. Read the label for age and dosing, especially for children and older adults
4. Avoid alcohol while taking either, particularly Benadryl

Actions that need medical guidance

• Choosing an antihistamine for an older adult
• Using an antihistamine alongside other sedating medications
• Allergy symptoms that a standard antihistamine doesn't control

Frequently asked questions

Sources

1. StatPearls (NCBI/NIH) — Antihistamines
2. Cleveland Clinic — Antihistamine Types & Side Effects
3. MedlinePlus (NIH/NLM) — Antihistamines for allergies

Sources for the specific figures on this page

1. Weiler JM, et al. — Effects of fexofenadine, diphenhydramine, and alcohol on driving performance: a randomized, placebo-controlled trial in the Iowa Driving Simulator. Annals of Internal Medicine, 2000;132(5):354–363. Forty licensed drivers with seasonal allergic rhinitis; driving performance was poorest after diphenhydramine, worse than after alcohol at approximately 0.1% blood alcohol concentration, and drowsiness ratings did not predict impairment.
2. StatPearls, NCBI Bookshelf (NIH) — Diphenhydramine. Peak plasma concentration around 1.5 hours, terminal half-life roughly 9 hours in adults, antimuscarinic effects, and its description as a high-risk medication in older patients because of fall risk from dizziness, sedation and hypotension.
3. DailyMed, U.S. National Library of Medicine — Diphenhydramine hydrochloride 25 mg — Drug Facts label. Dosing every 4 to 6 hours with no more than 6 doses in 24 hours, "children under 6 years of age: do not use", "do not use to make a child sleepy", excitability especially in children, the glaucoma, enlarged-prostate and breathing-problem flags, the instruction not to combine it with any other diphenhydramine product including topical ones, and the alcohol, sedative and driving warnings.
4. DailyMed, U.S. National Library of Medicine — Cetirizine hydrochloride — full prescribing information. Time to maximum concentration of approximately 1 hour, mean elimination half-life of 8.3 hours, and dose-related somnolence in about 14% of patients aged 12 and over.
5. DailyMed, U.S. National Library of Medicine — Cetirizine hydrochloride 10 mg — Drug Facts label. Once-daily directions, "drowsiness may occur", the alcohol and driving warnings, the "ask a doctor" flags for children under 6, adults 65 and over and liver or kidney disease, and the breastfeeding statement.
6. StatPearls, NCBI Bookshelf (NIH) — Antihistamines. First-generation agents crossing the blood-brain barrier versus second-generation peripheral selectivity, anticholinergic adverse effects, guidelines endorsing second-generation agents as first-line for allergic rhinitis and urticaria, and the 2024 American Geriatrics Society Beers Criteria classing first-generation antihistamines as potentially inappropriate in older adults.
7. U.S. Food and Drug Administration — Drug Safety Communication: FDA requires warning about rare but severe itching after stopping long-term use of the oral allergy medicines cetirizine or levocetirizine (Zyrtec, Xyzal and other trade names). 209 cases identified worldwide from reports received between 25 April 2017 and 6 July 2023.

Medical disclaimer: This guide is for general education and isn't a substitute for personalized medical advice. It doesn't provide dosing. Always talk to a qualified healthcare professional about your symptoms and treatment.

Related guides